Spanish Red Biotech Pipeline

Amgen

bemarituzumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Digestive System
Indication: overexpression of FGFR2b (FORTITUDE-301)
Phase: 1Phase I in Spain